Header Logo

A call for cost-effectiveness analysis for biologic therapies in chronic rhinosinusitis with nasal polyps.

A call for cost-effectiveness analysis for biologic therapies in chronic rhinosinusitis with nasal polyps. Ann Allergy Asthma Immunol. 2019 09; 123(3):232-239.

View in: PubMed